These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 6347283)
1. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man. Kehrl JH; Fauci AS Bull Eur Physiopathol Respir; 1983; 19(2):227-34. PubMed ID: 6347283 [TBL] [Abstract][Full Text] [Related]
2. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. Kehrl JH; Fauci AS J Clin Invest; 1983 Apr; 71(4):1032-40. PubMed ID: 6339558 [TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide. Nohr CW; Latter DA; Meakins JL; Christou NV Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597 [TBL] [Abstract][Full Text] [Related]
4. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. Lue C; Tarkowski A; Mestecky J J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993 [TBL] [Abstract][Full Text] [Related]
5. Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6. Ambrosino DM; Delaney NR; Shamberger RC J Immunol; 1990 Feb; 144(4):1221-6. PubMed ID: 2105993 [TBL] [Abstract][Full Text] [Related]
6. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response. Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533 [TBL] [Abstract][Full Text] [Related]
7. In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. Cupps TR; Gerin JL; Purcell RH; Goldsmith PK; Fauci AS J Clin Invest; 1984 Oct; 74(4):1204-13. PubMed ID: 6332826 [TBL] [Abstract][Full Text] [Related]
9. Subclass of individual IgA-secreting human lymphocytes. Investigation of in vivo pneumococcal polysaccharide-induced and in vitro mitogen-induced blood B cells by monolayer plaque-forming cell assays. Heilmann C; Barington T; Sigsgaard T J Immunol; 1988 Mar; 140(5):1496-9. PubMed ID: 2831268 [TBL] [Abstract][Full Text] [Related]
10. Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. Kehrl JH; Fauci AS Trans Assoc Am Physicians; 1983; 96():182-7. PubMed ID: 6208665 [TBL] [Abstract][Full Text] [Related]
11. Antigen-specific plaque-forming cell response of human cord blood lymphocytes after in vitro stimulation by T cell-dependent antigens. Van Tol MJ; Zijlstra J; Heijnen CJ; Kuis W; Zegers BJ; Ballieux RE Eur J Immunol; 1983 May; 13(5):390-7. PubMed ID: 6343096 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation. Teeuwsen VJ; Logtenberg T; Siebelink KH; Lange JM; Goudsmit J; Uytdehaag FG; Osterhaus AD J Immunol; 1987 Nov; 139(9):2929-35. PubMed ID: 3499462 [TBL] [Abstract][Full Text] [Related]
13. Triggering of human peripheral blood B cells: polyclonal induction and modulation of an in vitro PFC response. Friedman SM; Breard JM; Chess L J Immunol; 1976 Nov; 117(5 Pt.2):2021-8. PubMed ID: 792335 [TBL] [Abstract][Full Text] [Related]
14. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation. Braley-Mullen H J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides. Tvede N; Heilmann C; Christensen LD Clin Exp Immunol; 1989 Jun; 76(3):404-11. PubMed ID: 2787716 [TBL] [Abstract][Full Text] [Related]
16. Comparative studies on the actions of antigen and polyclonal B-cell activator in differentiation and proliferation of B-cells and B memory cells. Nakashima I; Nagase F; Yokochi T; Kojima T; Ohta M; Kato N Immunology; 1976 Oct; 31(4):649-58. PubMed ID: 789231 [TBL] [Abstract][Full Text] [Related]
17. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides. Yin JZ; Bell MK; Thorbecke GJ J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742 [TBL] [Abstract][Full Text] [Related]
18. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides. Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596 [TBL] [Abstract][Full Text] [Related]
19. Rapid changes in the regulatory potential of autologous anti-idiotopic T cells during an antigen-driven primary response. Cerny J; Cronkhite R; Stout JT J Immunol; 1986 May; 136(10):3597-606. PubMed ID: 2422258 [TBL] [Abstract][Full Text] [Related]
20. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]